Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_assertion type Assertion NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_head.
- NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_assertion description "[Because wild-type BRCA1 and BRCA2 gene products increase during cell-cycle progression and are believed to exert growth-inhibitory action, enhanced expression of these genes in cancer cells may represent a negative feedback mechanism for curbing proliferation in fast-growing cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_provenance.
- NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_assertion evidence source_evidence_literature NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_provenance.
- NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_assertion SIO_000772 10972993 NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_provenance.
- NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_assertion wasDerivedFrom befree-20150227 NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_provenance.
- NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_assertion wasGeneratedBy ECO_0000203 NP273320.RAPXu52cOroqCecF9DTL1i-XTB1DmWLazBF2RsfIytHz4130_provenance.